Terflavoxate

CAS No. 86433-40-1

Terflavoxate( —— )

Catalog No. M36117 CAS No. 86433-40-1

Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 418 Get Quote
10MG 616 Get Quote
25MG 908 Get Quote
50MG 1279 Get Quote
100MG 1683 Get Quote
500MG 3357 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Terflavoxate
  • Note
    Research use only, not for human use.
  • Brief Description
    Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
  • Description
    Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86433-40-1
  • Formula Weight
    419.51
  • Molecular Formula
    C26H29NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC(CN1CCCCC1)(C)C)(=O)C2=C3C(C(=O)C(C)=C(O3)C4=CC=CC=C4)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 62'-Dihydroxyflavone

    62'-Dihydroxyflavone is a novel antagonist of GABAA receptor.

  • TAT 14

    TAT 14, a 14-mer peptide, is an Nrf2 activator with anti-inflammatory properties. TAT-14 increases Nrf2 protein levels due to targeting the Nrf2 binding site on Keap1, but has no effect on Nrf2 mRNA expression.

  • Anidoxime HCl

    Anidoxime HCl (USVP-E142) is a novel orally available compound with anti-analgesic activity.